UT Neuroanesthesia / Neuro 2 · Day 7
Unit Cerebral aneurysm surgery Read 18 min Reviewed Sep 1, 2026 · JP Next review Aug 2027

Transmural Pressure

The pressure that distends an aneurysm and the pressure that perfuses the brain are the same subtraction. You cannot lower one without lowering the other, which means every manoeuvre that relaxes the brain also loads the aneurysm — and the patient who tolerates hypotension best is not the one you would guess.

Physiology · established Clinical claim · uncertain the pressure identity is arithmetic · the interventions built on it are mostly untested, and two of the big trials are negative
01

The pearl

Transmural pressure and cerebral perfusion pressure are the same number. Both equal mean arterial pressure minus intracranial pressure, so lowering the distending pressure across the aneurysm wall and preserving perfusion to the brain are not two goals — they are one quantity pulled in two directions. Two consequences follow and neither is intuitive: good-grade patients tolerate a larger fall in blood pressure than poor-grade patients, and a good-grade patient should not be hyperventilated, because dropping the intracranial pressure raises the transmural pressure across an unsecured aneurysm.

02

Why it is true

mechanism

There is one equation in this day, and it is not difficult. What is difficult is that it has two names.

One subtraction, two names

Transmural pressure is the pressure difference across the wall of the aneurysm — the thing that distends it and eventually tears it. It equals mean arterial pressure minus intracranial pressure.

Cerebral perfusion pressure is the pressure driving blood into the brain. It equals mean arterial pressure minus intracranial pressure.

They are numerically identical. Which means the two goals of this operation — minimise transmural pressure to avoid rupture and maintain perfusion pressure to avoid ischaemia — are exactly opposed. There is no setting that satisfies both. There is only a compromise, and the correct compromise depends on which risk this patient actually carries.

A perfusion pressure of 60 to 80 mm Hg is a reasonable general goal. The rest of the day is about when to sit above it and when to sit below it.

Grade determines the compromise

The clinical grade is not a formality. It predicts, in order: intracranial pressure, the state of autoregulation, cardiac dysfunction, hypovolaemia and hyponatraemia, and the risk of vasospasm. Intracranial pressure of at least 20 mm Hg is present in 36 to 67% of patients after subarachnoid haemorrhage, and it correlates with grade — generally normal in grades I and II, elevated in IV and V.

That produces the counter-intuitive rule.

Good grades (0, I, II) have normal intracranial pressure and are not ischaemic. They tolerate a bigger transient fall in blood pressure — 30 to 35%, a systolic around 100 mm Hg. And they should not be hyperventilated, because reducing cerebral blood flow reduces intracranial pressure and therefore raises transmural pressure.

Poor grades have raised intracranial pressure, low perfusion pressure and ischaemia. The elevated pressure decreases transmural pressure and partially protects the aneurysm from rerupture. They tolerate hypotension poorly, so the depth and duration of any fall is moderated, and they are the patients managed with moderate hyperventilation to improve perfusion.

The general principle for induction is a reduction of 20 to 25% below baseline with prophylaxis against the intubation response, and the general principle for everything is that the change should always be gradual, never abrupt.

A normal intracranial pressure, incidentally, does not mean normal compliance. The reserve can be gone with the number still reading 12.

Why the pressure matters more here than elsewhere

Two pieces of physiology explain the anxiety.

Autoregulation is impaired, and the lower limit has shifted right. The severity tracks the clinical grade — Nornes and colleagues found the lower limit significantly higher in grade III than in grades I and II during intracranial surgery. Impaired autoregulation in the presence of vasospasm predicts delayed ischaemic deficits and unfavourable outcome. There are well-documented cases of a new deficit appearing with a fall in blood pressure and reversing when the pressure was restored pharmacologically. You must not let the perfusion pressure fall below a limit you cannot measure and which is higher than normal.

Wall tension rises with pressure and with size. By the law of Laplace, wall tension is the product of pressure and radius divided by two — so for any given blood pressure, wall stress is higher in an aneurysmal sac than in a normal artery, and higher in a large aneurysm than in a small one. That is the classical justification for lowering blood pressure during dissection, and it is the reason giant aneurysms, over 2.5 cm, are a different operation.

Induction is the dangerous part

Rupture at induction is rare — reported at 2% in one series, probably under 1% with modern technique — and is usually precipitated by a sudden rise in blood pressure at intubation. It carries a high mortality.

It is useful to think of induction as two separate problems:

Loss of consciousness. Propofol 1.5 to 2 mg/kg with fentanyl 3 to 5 µg/kg, sufentanil 0.3 to 0.5 µg/kg, or remifentanil 0.5 to 1.5 µg/kg. Etomidate 0.3 to 0.4 mg/kg and midazolam 0.1 to 0.2 mg/kg are alternatives.

Prophylaxis against the laryngoscopy response, which is a separate drug decision requiring separate drugs: high-dose opioid (fentanyl 5 to 10 µg/kg, sufentanil 0.5 to 1.0 µg/kg, remifentanil 1 to 1.5 µg/kg), esmolol 0.5 mg/kg, labetalol 10 to 20 mg, lidocaine 1.5 to 2.0 mg/kg, a second dose of propofol, or deep inhalational anaesthesia. Intravenous adjuncts are preferred in poor grades; deep volatile suits good grades but should be avoided with raised intracranial pressure.

Two rules make this safer than any drug list. Intubate only when paralysis is complete, monitored — coughing is a transmural pressure event. And if the blood pressure begins to rise unexpectedly during laryngoscopy, stop, ventilate, deepen, and try again.

The arterial line goes in before induction where possible, transduced at the level of the base of the skull and re-zeroed with any change in position, because it is standing in for perfusion pressure and not for systemic pressure.

Relaxing the brain, at a price

Every manoeuvre here reduces one of the three intracranial compartments, and every one of them raises transmural pressure. That is today’s pitfall, so here only the numbers.

Mannitol 20%, 0.5 to 2 g/kg — usually 0.5 to 1 — given over 30 minutes. Onset 4 to 5 minutes, peak 30 to 45. Given faster than 10 minutes it drops peripheral vascular resistance and causes transient hypotension, followed by a rise in central venous pressure and cardiac output. A serum osmolarity above 320 mOsm is the conventional ceiling for further dosing (a weakly-evidenced threshold) — the same ceiling as Neuro 2 day 03. Hypertonic saline 3% is a reasonable alternative, with no difference in brain relaxation and lower volume shift.

Cerebrospinal fluid drainage by lumbar catheter. The average adult has about 150 mL of cerebrospinal fluid; 20 to 30 mL is usually drained just before dural opening, at a rate not exceeding 5 mL/min. Contraindicated with an intracerebral haematoma.

Hyperventilation. Cerebral blood flow changes 2 to 3% per mm Hg of PaCO₂ within the physiologic range; blood volume changes about 1% per mm Hg. Mild hypocapnia 30 to 35 mm Hg before the dura is open, moderate 25 to 30 after, relative normocapnia after the clip.

Position. Ten degrees of reverse Trendelenburg improves intracranial pressure while maintaining perfusion pressure.

And when the brain stays tight despite all of it, the source gives a checklist worth memorising because it is mostly not pharmacological: exclude hypoxaemia and systemic hypertension; check the head and neck position for venous obstruction; check the drain is patent; stop nitrous oxide; head-up tilt after telling the surgeon; then a test bolus of propofol 100 to 200 mg and an infusion at 150 to 200 µg/kg/min if it helps. Occasionally the answer is that there is an intracerebral haematoma.

Failure to inspect head and neck position before draping is named as a common cause of unexplained intraoperative cerebral swelling. Tape the tube rather than tying it, so a tie cannot slip and tighten around the neck.

Hypotension is out; occlusion is in

Deliberate hypotension was standard for decades and is now exceedingly rare. Impaired autoregulation after subarachnoid haemorrhage, an unpredictable cerebrovascular response, an increased risk of vasospasm and reported poorer outcomes retired it. In a patient with vasospasm it is contraindicated.

Temporary occlusion of the feeding artery replaced it, and the two differ in almost every respect:

Temporary occlusionControlled hypotension
Systemic pressurenormotension or hypertensionsystemic hypotension
Flowtemporarily ceaseduninterrupted
Ischaemiaregionalglobal
Durationshort, 10–20 minlonger
Collateralsdepends on themindependent of them
Vessel damagepossiblenone
Control of bleedingpossibly completeincomplete

The clock matters. Five to seven minutes with prompt reperfusion is usually well tolerated but is often not long enough for a difficult aneurysm. Fifteen to twenty minutes is generally taken as the upper limit of safety, and occlusion under 20 minutes is associated with better outcomes. In Samson’s series, every patient occluded longer than 31 minutes infarcted, and older patients in poorer condition tolerated occlusion less well.

Restore the blood pressure to normal before the temporary clips are applied. The technique depends on collateral flow, and collateral flow depends on pressure.

Where a broad neck makes even temporary clipping difficult, adenosine can produce a transient cardiac standstill: a dose-response established with two or three incremental doses of 6 to 18 mg, then about 30 seconds of asystole at an average of 30 to 36 mg. Recovery is spontaneous, often with rebound tachycardia and hypertension. It is contraindicated with pre-existing conduction abnormalities or severe asthma.

Protecting the brain, honestly

The theory is clean: reduce cerebral metabolic rate and the tissue distal to the clip tolerates ischaemia longer. Thiopental, etomidate and propofol have all been used, titrated to burst suppression on EEG within 2 to 3 minutes. Suzuki’s high-dose mannitol at 2 g/kg, and the “Sendai cocktail” of mannitol with vitamin E and dexamethasone, come from the same idea. Lavine and colleagues reported that brain-protective therapy extended tolerable occlusion from 12 to 19 minutes without infarction.

Four honest qualifications belong with that:

  • There are no randomised trials of pharmacologic neuroprotection for temporary occlusion, and the source says plainly it does not have sufficient data to support routine use.
  • Additional drug may not reach the ischaemic tissue if the collateral supply is inadequate — though what did arrive will linger, because there is no flow to wash it out.
  • Etomidate may cause cerebral tissue hypoxia during temporary occlusion despite reducing global metabolic rate, on brain oxygen tension measurement.
  • Burst suppression and motor evoked potentials fight each other. The depressive effect on signal quality can be so pronounced that the motor response is lost completely. You cannot maximise both the protection and the monitoring that would tell you whether it was needed.

Mild hypothermia is the cleanest result in the chapter and it is negative: IHAST found no effect on neurologic outcome at 33.5°C in good-grade patients, and — a detail worth keeping — no coagulopathy either. The manoeuvre is not dangerous. It just does not help the patients who were studied.

When it ruptures

The Cooperative Study reported a leak in about 6% and frank rupture in 13%, a combined 19%; a later series reported 3.8% frank and 7.9% overall. Batjer and Samson found the timing: 7% before dissection, 48% during dissection, 45% during clip application. In roughly 8% of the Cooperative Study’s ruptures there was frank haemorrhagic shock.

Management divides on whether volume is being lost:

  • Small leak, dissection complete — the surgeon gains control with suction and clips the neck.
  • Temporary occlusion possible — proximal and distal clips, which is the preferred route, with propofol or etomidate for some protection before the clip. Maintain normotension during occlusion.
  • Occlusion impossible, blood loss not significant — transiently drop the mean arterial pressure to 50 mm Hg or lower to let the surgeon see.
  • Frank haemorrhage — resuscitate first. Cerebroprotective agents may not be giveable because of their haemodynamic effects, and induced hypotension is not available until volume is restored.

A video monitor showing you the field is named as a genuine aid here, which is a reminder that the anaesthetic response to this event depends on watching the surgery rather than the numbers.

Vasospasm, and a reconciliation

Angiographic vasospasm is not seen before 72 hours, peaks at day 7, and is seldom seen after two weeks. Cerebral blood flow can fall 20 to 25% without symptoms, so considerable narrowing is silent — and of those who do become symptomatic, about half die or are left with serious deficit.

Two things about treatment carry beyond this day. Nimodipine works without improving the angiogram, which is in today’s synthesis. And triple-H has become hypertensive therapy, because hypervolaemia adds no benefit and may worsen pulmonary dysfunction. Blood pressure is titrated to reversal of symptoms, up to 160 to 200 mm Hg systolic if the aneurysm is clipped and only 120 to 160 if it is not.

Which raises an apparent conflict with Neuro 1 day 15 and Neuro 2 day 06, both of which treat SIADH with fluid restriction.

It is not a contradiction — it is a different context. Hyponatraemia occurs in 30 to 57% of subarachnoid haemorrhage, and intravascular volume is abnormally low in 36 to 100% of these patients. Because hypovolaemia aggravates vasospasm and is associated with cerebral ischaemia and infarction, restricting fluid here trades a sodium problem for an infarct. So in subarachnoid haemorrhage the source says normovolaemia is the goal but it is safer to err on the hypervolaemic side, and hypertonic saline is the treatment of choice for both SIADH and cerebral salt wasting. Elsewhere, with no vasospasm risk, restriction is reasonable. The difference in management follows from the difference in what else the patient is at risk of.

Waking up

The stimulus profile inverts during the case — pins, then bone flap, then almost nothing once the dura is open — so the anaesthetic must be planned around it rather than around the clock.

Grade I and II patients after an uneventful clipping should wake and be extubated in theatre. Lidocaine 1.5 mg/kg suppresses cough but lasts only 3 to 5 minutes and can be repeated. Grade III is a judgement, and the source says err towards caution. Grades IV and V stay ventilated.

Blood pressure on emergence is managed to a different rule than during the case, because the aneurysm is now secured and hypertensive therapy is what reverses delayed ischaemia: modest hypertension below 180 mm Hg systolic is not treated aggressively, while above 200 risks swelling or haemorrhage. Labetalol in 5 to 10 mg increments or esmolol in 0.1 to 0.5 mg/kg increments.

Unless there are multiple aneurysms. Then the pressure is kept within 20% of the patient’s normal, because the ones that were not clipped are still subject to the equation this day is named for.

Finally, the rules for telling a slow wake-up from a surgical catastrophe: anaesthesia causes global depression, so any new focal deficit should be assumed surgical; volatile effects should have largely gone by 30 to 60 minutes; mid-sized reactive pupils with unimpaired respiration argue against opioid excess; and new unequal pupils always suggest a surgical event. Neurological status is assessed every 15 minutes, and sometimes the answer is a scan.

Wanted low — rupture risk Wanted high — ischaemia risk Manoeuvres that do both at once
ONE SUBTRACTION, TWO NAMES, OPPOSITE TARGETS MAP − ICP one quantity Transmural pressure wanted LOW or the aneurysm ruptures Perfusion pressure wanted HIGH or the brain infarcts Numerically identical — so there is no setting that satisfies both TARGET CPP 60–80 mm Hg · CHANGE GRADUALLY, NEVER ABRUPTLY WHICH RISK DOES THIS PATIENT ACTUALLY CARRY? GOOD GRADE · Hunt and Hess 0–II ICP normal · not ischaemic Tolerates a 30–35% fall in pressure Systolic around 100 mm Hg is acceptable DO NOT hyperventilate before the clip Lowering ICP only widens the gradient THE RISK HERE IS RUPTURE POOR GRADE · IV–V ICP raised · CPP low · ischaemic The raised ICP is partly protecting the aneurysm from rerupture Moderate hyperventilation is used here Hypotension tolerated poorly — moderate it THE RISK HERE IS ISCHAEMIA GRADE III — DECIDE WITH THE SURGEON EVERY MANOEUVRE THAT RELAXES THE BRAIN ALSO RAISES TRANSMURAL PRESSURE Hyperventilation CSF drainage Mannitol 30–35 before dura, 25–30 after 20–30 mL, ≤5 mL/min full dose over 30 min · ceiling 320 mOsm
Figure 1. The identity in the centre is the whole day. Because the same subtraction produces both quantities, there is no setting of blood pressure and intracranial pressure that optimises both, and the correct compromise depends on which risk the patient actually carries. The bottom row is the part that surprises people: raised intracranial pressure is partly protecting the poor-grade patient's aneurysm, and relieving it is not a free good.
03

The evidence

the pressure identity is arithmetic · the interventions built on it are mostly untested, and two of the big trials are negative

ISAT

Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360(9342):1267-1274. Benefit
Design
International multicentre randomized trial, 43 centres
Population
2143 patients with ruptured intracranial aneurysms judged suitable for either endovascular coiling or neurosurgical clipping
Intervention
Endovascular coiling
Control
Neurosurgical clipping
Primary
Death or dependence (modified Rankin 3–6) at 1 year
Result
Outcome favoured coiling, and the trial was stopped early by its steering committee. This is the result that made coiling the more common way an intracranial aneurysm is secured.

What "amenable to both" concealed Randomization required the aneurysm to be treatable either way, so the trial deliberately excluded the anatomy that forces a decision. It does not tell you what to do about an aneurysm only one modality can reach, and that is a large share of the ones you will anaesthetise for.

ISAT 18-year follow-up

Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691-697. Benefit
Design
Long-term follow-up of the UK cohort of the ISAT randomized trial
Population
1644 patients from the UK centres, followed for a mean of about 18 years
Intervention
Endovascular coiling
Control
Neurosurgical clipping
Primary
Death, and recurrent subarachnoid haemorrhage from the treated aneurysm
Result
The probability of survival was greater after coiling, and the survival advantage present at the original analysis persisted. The rate of recurrent haemorrhage from the treated aneurysm was higher after coiling but small in absolute terms.

A durability question answered, not dismissed The follow-up settles that the early advantage does not evaporate, but it also confirms the mechanism sceptics predicted: coiled aneurysms do rebleed more often. The right reading is a trade-off with a known shape, not a clean win.

IHAST

Todd MM, Hindman BJ, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352(2):135-145. No benefit
Design
Multicentre randomized trial
Population
1001 patients with good-grade aneurysmal subarachnoid haemorrhage undergoing surgical clipping within 14 days of the bleed
Intervention
Intraoperative cooling to a target of 33.5°C
Control
Normothermia at 36.5°C
Primary
Glasgow Outcome Score at approximately 90 days
Result
No effect on neurological outcome. Notably, no significant complications were seen in the hypothermia group either — specifically no coagulopathy — so the trial is a clean negative rather than a harm signal.

The patients it did not enrol Only good-grade patients were randomized, and the trial was not designed to test hypothermia during prolonged temporary occlusion. The two situations where cooling is most often argued for — poor grade, and a long clip time — remain unstudied.

MASH-2

Dorhout Mees SM, Algra A, Vandertop WP, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012;380(9836):44-49. No benefit
Design
Multicentre randomized placebo-controlled trial
Population
1204 patients with aneurysmal subarachnoid haemorrhage
Intervention
Intravenous magnesium sulphate
Control
Placebo
Primary
Poor outcome, defined as a modified Rankin score of 4 to 5 or death, at 3 months
Result
No benefit. Combined with earlier trials in a meta-analysis, magnesium does not improve outcome after aneurysmal subarachnoid haemorrhage.

Why a plausible drug failed Magnesium blocks voltage-dependent calcium channels and antagonises NMDA receptors, which is exactly the mechanism story told for nimodipine. That a drug with the right mechanism failed is the reason mechanistic reasoning cannot substitute for a trial here.

Put the four trials beside the physiology and a pattern appears that is worth more than any single result.

The arithmetic is certain and the interventions built on it are not. That transmural pressure equals mean arterial pressure minus intracranial pressure is not a finding, it is a definition, and everything the day recommends about the direction of a manoeuvre follows from it reliably. But the specific things done in the name of protecting the brain during clipping — cooling, burst suppression, magnesium — have either failed when tested or have never been tested at all.

The two negative trials are the ones that changed the operating room. IHAST removed routine mild hypothermia from good-grade aneurysm surgery. MASH-2 removed magnesium. Both drugs and manoeuvres had good mechanistic stories, and both stories were wrong about outcome. Pharmacologic neuroprotection during temporary occlusion is in the same position now: plausible, widely practised, and without sufficient data to support routine use.

The one drug that works does not work the way its name suggests. Nimodipine is the only class shown consistently to reduce morbidity and mortality from vasospasm — poor outcome reduced by 40 to 70% depending on the study — and yet none of the favourable trials demonstrated any change in the incidence or severity of angiographic vasospasm. Whatever nimodipine does, it is not relieving the spasm you can see on the angiogram. Hold both facts: give it, and do not expect the angiogram to improve.

And the same logic retired triple-H. Hypervolaemia, hypertension and haemodilution were given together for decades on a coherent rationale. Repeated study suggests hypervolaemia adds no benefit and may increase pulmonary dysfunction, so current guidance is essentially hypertensive therapy alone. The component that survived is the one acting directly on the perfusion pressure this day is about.

04

What you actually do

in the room
  1. Say the identity out loud before you touch the blood pressure. Transmural pressure and cerebral perfusion pressure are both mean arterial pressure minus intracranial pressure. Lowering rupture risk and preserving perfusion are one lever, not two, and a perfusion pressure of 60 to 80 mm Hg is a reasonable working goal.
  2. Set the induction blood pressure target from the clinical grade, not a protocol. As a general principle reduce blood pressure 20 to 25% below baseline and give prophylaxis against the intubation response. Grades 0, I and II have normal intracranial pressure and no ischaemia, so they tolerate a larger transient fall — 30 to 35%, systolic around 100 mm Hg. Poor grades have raised pressure, low perfusion pressure and ischaemia, and tolerate it badly.
  3. Do not hyperventilate a good-grade patient before the aneurysm is secured. Reducing cerebral blood flow lowers intracranial pressure, and lowering intracranial pressure raises transmural pressure across the aneurysm. Poor grades are the ones managed with moderate hyperventilation, to improve cerebral perfusion. Carbon dioxide reactivity survives after subarachnoid haemorrhage even when autoregulation does not, so hyperventilation still works — which is precisely why it can be used in the wrong direction.
  4. Make every change gradual. Whichever way transmural pressure or perfusion pressure is moving, it should move slowly. Abrupt change is the mechanism of both rupture and ischaemia, and it is the reason a normal intracranial pressure should not be normalised quickly.
  5. Drain cerebrospinal fluid slowly, late, and not at all in some patients. In theory free drainage waits until the dura is open; in practice 20 to 30 mL is drained just before dural opening. The rate should not exceed 5 mL/min, because rapid drainage can cause sudden reflex hypertension from downward movement of the brainstem. Lumbar drainage is contraindicated with an intracerebral haematoma because of brainstem herniation.
  6. Prefer temporary occlusion to induced hypotension, and give the pressure back before the clip goes on. Deliberate hypotension is now exceedingly rare — autoregulation is impaired after subarachnoid haemorrhage, the cerebrovascular response is unpredictable, and outcomes have been poorer. Temporary occlusion produces regional rather than global ischaemia, and depends on collateral flow, so blood pressure should be restored to normal before the temporary clips are applied to maximise that collateral supply.
  7. Know the occlusion clock. Five to seven minutes is usually well tolerated. Fifteen to twenty minutes is generally taken as the upper limit of safety, with under twenty minutes associated with better outcomes. In one series every patient occluded for more than 31 minutes infarcted. Ask for the time out loud and keep asking.
  8. Anticipate the stimulus profile, because it inverts mid-case. Noxious stimulation begins with the pins, intensifies as the bone flap is raised, and then once the dura is open there is little or no surgical stimulation at all. An anaesthetic depth appropriate to the first half produces hypotension in the second. Posterior fossa aneurysms are the exception — brainstem and cranial nerve retraction can cause sudden hypertension or bradycardia.
05

The pitfall

Everything that relaxes the brain loads the aneurysm

The brain is tight. The surgeon has said so. You have a familiar list: hyperventilate, drain cerebrospinal fluid, give mannitol, tilt the head up. Every item on that list works by reducing intracranial pressure.

And intracranial pressure is the term you subtract to get transmural pressure. Reduce it, and the distending pressure across the wall of an unsecured aneurysm goes up by exactly the same amount. The source states the principle plainly: it is important not to normalize the intracranial pressure too rapidly, because doing so may increase the transmural pressure gradient and cause further haemorrhage.

So the brain-relaxation manoeuvres are not neutral before the clip is on. They are a transaction, and the price is rupture risk.

Three specific traps follow.

Hyperventilating the well patient. A good-grade patient has a normal intracranial pressure and no ischaemia. There is nothing to relieve, and lowering the pressure only widens the gradient. Carbon dioxide reactivity is preserved after subarachnoid haemorrhage even in patients whose autoregulation is not, so the manoeuvre will work — the problem is that it works in the wrong direction. Mild hypocapnia of 30 to 35 mm Hg before the dura is open, moderate hypocapnia of 25 to 30 after it, is the ordering the source gives, and the order is the point.

Draining too fast. Twenty to thirty millilitres is usually taken just before the dura is opened, and the rate should not exceed 5 mL/min. Faster than that and the intracranial pressure falls abruptly; the transmural pressure rises with it, and the brainstem moves downward, which can produce a sudden reflex hypertension that widens the gradient from the other side as well. And with an intracerebral haematoma, lumbar drainage is not slow-and- careful, it is contraindicated.

Mannitol before the dura is open. In theory it should not be given, both because of the fluctuation in intracranial pressure and because shrinking the brain can tear bridging veins. In practice a slow infusion of 100 to 200 mL/h is started after final positioning and increased to 400 to 500 mL/h once the bone flap is up. The full dose goes in over 30 minutes, not faster, because rapid administration drops peripheral vascular resistance and causes transient hypotension — the other half of the same subtraction.

Now invert the trap, because the inversion is what actually catches people.

In a poor-grade patient, the raised intracranial pressure is partly protecting the aneurysm. These patients have elevated pressure, low perfusion pressure and ischaemia, and the elevated pressure is holding the transmural gradient down. That is why they tolerate hypotension badly and why the reflex to "fix the number" is dangerous. The pressure you are looking at is doing two jobs, and only one of them is bad.

The reconciliation is not a rule to memorise. It is a question to ask before each manoeuvre: which of the two quantities am I about to move, and does this patient have more to fear from rupture or from ischaemia? Grade 0 to II, the answer is usually rupture. Grade IV to V, it is usually ischaemia. Grade III, you decide with the surgeon.

06

Sources

primary first

Full text · Preston goes through LibKey to whatever Preston holds — the PDF where there is one — and works on a phone. The doi link always reaches the publisher's record, whether or not we hold a subscription. If you are reading on a computer, LibKey Nomad adds the same one-click PDF button to PubMed and publisher pages everywhere else; it is a desktop browser extension, so it does nothing on a phone or tablet.

07

Check yourself

3 items · one attempt each
Item 1 Analysis Neuro 2 · Day 7

A Hunt and Hess grade I patient is anaesthetised for clipping of an anterior communicating artery aneurysm. Before the dura is opened, a trainee suggests hyperventilating to PaCO₂ 25 mm Hg to improve exposure. What is the objection?

Item 2 Application Neuro 2 · Day 7

The surgeon is about to apply temporary clips proximal and distal to a middle cerebral artery aneurysm. What should you do with the blood pressure?

Item 3 Recall Neuro 2 · Day 7

Which statement about nimodipine after aneurysmal subarachnoid haemorrhage is correct?

↻

Returning items

from earlier this rotation
Day 01 On T1 and T2, how do CSF and most pathology appear — and which sequence is contrast given with?

That is the whole orientation rule. Fat is bright on T1 and intermediate on T2, cortical bone gives no signal, and flowing blood produces a signal void. The practical summary is that anatomy is better seen on T1 and pathology on T2 — and post-contrast sequences are T1 weighted for exactly the reason given.

Day 01 A patient with a clipped aneurysm needs an MRI. What determines whether they can have one?

Ferromagnetic aneurysm clips are a contraindication; non-ferromagnetic ones are not. The risk from a ferromagnetic object is magnetically induced movement, with dislodgement and injury, and heating — image artefact is the secondary concern. The information you need is in the old operation note, not on any current imaging.